AI assistant
Sending…
CASTLE BIOSCIENCES INC — Director's Dealing 2020
May 12, 2020
32601_dirs_2020-05-12_d0f3cd07-af0d-4b0b-a965-b2b26c6db56a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-05-08
Reporting Person: Spiess Bernhard E. (Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-08 | Common Stock | M | 32233 | $1.92 | Acquired | 157859 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-08 | Stock option (right to buy) | $1.92 | M | 32233 | Disposed | 2026-05-23 | Common Stock (32233.0) | Direct |
Footnotes
F1: 25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
More from CASTLE BIOSCIENCES INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 26
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Jan 22